New Study Examines Time-Related Relationship Between Diabetes and Cancer
Patients with diabetes are more likely to get a cancer diagnosis ten years prior or three months after their diabetes diagnosis, according to a recent study.
BY Brielle Urciuoli
PUBLISHED July 18, 2016
Type 2 diabetes is associated with an increased likelihood of a cancer diagnosis, according to the recent findings of a large Canadian study.
The strongest correlation was 10 years prior and three months after a diabetes diagnosis, according to the study, which was conducted by Iliana Lega and her colleagues at the University of Toronto.
People with diabetes were more likely to have been diagnosed with a first cancer within the decade before diabetes diagnosis, when compared with those without diabetes. Once diagnosed with diabetes, there is a spike in cancer occurrence in the first three months, as those with diabetes had a 62 percent greater chance of being diagnosed with cancer than those without diabetes.
“This may, in part, be explained by increased health care visits and screening tests following a diagnosis of diabetes,” Lega said in a statement.
After the three-month mark, the difference in cancer statistics between those with diabetes and those without leveled off.
But while detection bias may play a role in the number of cancer diagnoses within the first few months of a diabetes diagnosis, the reason for the higher prevalence (23 percent) of cancer a decade prior likely has more to do with the risk factors leading up to diabetes, independent of seeing a doctor.
“This observation may be due to shared metabolic risk factors for diabetes and cancer that are present during the prediabetes period, such as insulin resistance and hyperinsulinemia,” the study’s authors wrote. “These metabolic alterations may precede a clinical diagnosis of diabetes by up to 10 years.”
The study looked at 516,219 patients with diabetes, and matched them with a control group of 516,219 non-diabetics. All patients were 30 years of age or older, leading the study to reflect cancer risk for type 2 diabetes, since type 1 diabetes is rare in this age group, Lega said in an interview with CURE.
Diabetes was associated with a “significantly increased risk” of pancreatic, endometrial, liver and thyroid cancers in both time periods studied. There was a jump in colorectal and bladder cancers within the first three months of a diabetes diagnosis, but it then leveled off.
As diabetes rates continue to grow in many countries, including the United States, the authors of the study emphasized the importance of intervention and prevention.
“We have excellent evidence that diabetes can be reversed with physical activity and lifestyle interventions in high-risk individuals,” the study’s authors wrote. “Such interventions are urgently needed both on an individual and population level, not only to reduce the risk of diabetes and vascular complications, but also to potentially reduce the burden of cancer in this population.”
Further, Lega mentioned that increased screening could improve outcomes for people with diabetes who may potentially have cancer as well.
“Our findings suggest that people with diabetes, and even those at risk for diabetes, may have a higher risk of cancer and therefore may benefit from enhanced cancer screening and prevention programs,” she said. “However, more research is needed to assess how to best implement such targeted programs in this high-risk population.”